Name: 欧洲炭疽病治疗市场 – 行业趋势和 2029 年预测
Brand: Data Bridge Market Research
SKU: 68919
Price: 3500.00 USD
Availability: InStock
Rating: 4.5 (51 reviews)

欧洲炭疽病治疗市场，按类型（皮肤炭疽病、肺炭疽病和肠炭疽病）、给药途径（口服、肠外和其他）、最终用户（政府组织、医院、学术和研究机构等）划分的行业趋势和预测到 2029 年。

炭疽病治疗市场

欧洲炭疽病治疗市场分析与洞察

欧洲炭疽病治疗市场受到多种因素的推动，例如细菌感染发病率上升、研究资金增加、炭疽病治疗新疗法的开发和管道产品增加了对炭疽病治疗的需求，以及研发投资的增加导致市场增长。目前，发达国家和新兴国家的医疗保健支出都有所增加，这有望为制造商开发新的创新产品创造竞争优势。

炭疽病治疗市场

全球患炭疽病的人数增加是推动炭疽病治疗市场增长的主要因素之一。研究人员为开发新型干预措施而获得的财政支持增加，以及平民和军队接触炭疽杆菌的威胁增加，加速了市场的增长。研发项目数量的增加，以及为促进创新和有效治疗的新发展而建立的公私伙伴关系的增加，进一步影响了市场。然而，治疗和程序的高成本以及政府对产品审批的严格规定预计将阻碍炭疽病治疗市场的增长。

欧洲炭疽病治疗市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入来源、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情景，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。各地区发展中国家零售单位的可扩展性和业务扩展以及与供应商合作安全分销机器和药品是推动预测期内市场需求的主要驱动力。

欧洲炭疽病治疗市场具有支持性，旨在减缓疾病的进展。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，欧洲炭疽病治疗市场将以 5.7% 的复合年增长率增长。

报告指标	细节
预测期	2022 至 2029 年
基准年	2021
历史岁月	2020（可定制至 2019 - 2014）
定量单位	收入（百万美元），定价（美元）
涵盖的领域	按类型（皮肤炭疽、肺炭疽和肠炭疽）、给药途径（口服、肠外和其他）、最终用户（政府组织、医院、学术和研究机构和其他）划分的行业趋势和预测（至 2029 年）
覆盖国家	德国、法国、意大利、英国、西班牙、荷兰、俄罗斯、瑞士、土耳其、比利时、欧洲其他地区
涵盖的市场参与者	Alembic Pharmaceuticals、Sun Pharmaceutical Industries Ltd.、Zydus Group、Bayer AG、Pfizer Inc.、EMERGENT、Sanofi、Porton Biopharma、Lupin、Soligenix、Takeda Pharmaceutical Company Limited、Teva Pharmaceutical Industries Ltd.、ARISTO Pharmaceuticals Private Limited、INDOCO REMEDIES LTD.、DEINOVE 等

欧洲炭疽病治疗市场动态

市场定义

炭疽病是由一种名为炭疽芽孢杆菌 (B. anthracis) 的细菌引起的。它主要是一种牲畜疾病，通过摄入土壤中的孢子而感染。人类通常通过接触受感染动物的产品（如皮革或羊毛）或吸入受感染动物产品中的炭疽孢子而感染炭疽病。他们也可能通过食用受感染动物的未煮熟的肉而感染。据了解，炭疽病不会在人与人之间传播。

炭疽感染有三种临床形式。皮肤炭疽是最常见的，占已报告病例的 95% 以上。据估计，全球每年发生 2000 例皮肤炭疽病例，是由孢子通过皮肤擦伤进入人体引起的。

炭疽病的鉴别诊断包括根据临床特征，相关标本包括PCR、革兰氏染色和培养，来自血液、胸腔积液、溃疡部位、脑脊液和粪便。有许多可用的技术。大多数检测是基于通过以下技术之一检测整个生物体、生物体抗原或生物体核酸：基于培养的常规方法；免疫学检测；基于核酸的检测；基于配体的检测；以及生物传感器。

驱动程序

炭疽病感染率不断上升

细菌感染的发病率在世界范围内不断上升。炭疽病是由炭疽芽孢杆菌引起的细菌感染，炭疽芽孢杆菌是一种需氧革兰氏阳性芽孢杆菌。根据炭疽芽孢杆菌孢子的进入途径，炭疽病主要以皮肤、肺部或胃肠道感染的形式出现。随后，受感染的皮肤区域会出现典型的黑色硬皮斑点，几周后开始松弛并最终脱落，留下疤痕。这些事件的进程非常典型，熟悉该疾病的医生通常不会漏诊，尽管这种情况很少见。肺炭疽是三种炭疽病中最致命的一种，其中的孢子一旦被吸入，就会在气管支气管淋巴结内发芽并繁殖。炭疽病是一种影响人类和动物的有害疾病。它是一种由炭疽芽孢杆菌引起的危及生命的感染。因此，炭疽病感染的发病率和流行率不断上升，需要更多灵敏度更高的诊断方法来检测少量感染。

全球患炭疽病的人数增加是推动炭疽病治疗市场增长的主要因素之一。研究人员为开发新型干预措施而获得的财政支持增加，以及平民和军队接触炭疽杆菌的威胁增加，加速了市场的增长。研发项目数量的增加，以及促进创新有效治疗的新发展的公私伙伴关系的增加，进一步影响了市场。

增加研究资金和开发针对炭疽病治疗人群的新疗法

研发是改进治疗不同类型患者的程序的先决条件。全球各国对炭疽病治疗的需求都在增加。这就是为什么各公司不断专注于研发，以成功为患者提供有效的治疗。近年来，许多诊断方法的出现将诊断提升到了新的水平，许多方法甚至可以用来检测人体内最小量的寄生虫。

这些新的诊断方法将推动市场向前发展。随着研究资金的增加和治疗炭疽病的新疗法的开发。有几种新型和现有的抗生素以及毒素抑制剂显示出越来越大的前景，它们针对细菌生长和毒素产生，有效对抗炭疽细菌。

随着公司不断从事开发活动，市场上推出了更多创新产品。开发的新工具能够以更高的有效率在更短的时间间隔内检测细菌感染，从而使消费者能够在正确的时间获得适当的治疗。因此，这意味着不断增加的研究和开发有望成为欧洲炭疽病治疗市场增长的动力

机会

新品发布

人类感染通常是通过接触受感染的动物或动物产品，并可能表现为皮肤、吸入或胃肠道感染。炭疽病的全球发病率普遍上升。因此，全球越来越多的患者需要高效和先进的炭疽病治疗产品，以最大限度地降低因炭疽病死亡的风险。此外，发达国家的医疗保健系统更倾向于高进步、风险因素较少和先进的炭疽病治疗产品。因此，主要市场参与者高度关注产品发布。

因此，不断增加的产品发布提供了高效和先进的医疗产品，以改善患者体验。新产品的发布不仅引起了公司的关注，还为公司在欧洲市场建立了影响力。产品发布的根本有利因素是促进了公司的业务增长。而新产品的发布为公司创造了收入来源，而产品发布所建立的收入来源可以持续多年。因此，据估计，新产品的发布有望为市场参与者带来巨大的机会，以提升他们在炭疽病治疗市场的业务增长。

限制/挑战

治疗费用高昂

产品成本是市场的主要因素。市场上有许多诊断选项，但由于成本高昂，大多数人倾向于避免进行诊断。由于诊断方法具有更高的灵敏度和特异性，因此测试成本也增加了。该程序的高成本是由于治疗的各种检查点以及使用高科技方式执行此类程序。由于技术先进设备的成本很高，因此程序成本也会相应增加，因此预计程序的高成本将阻碍市场的需求。

此外，无症状感染者必须经过非常特殊的测试才能识别出细菌，而这些测试成本高昂。由于炭疽病的诊断成本高昂，预计会抑制市场增长。由于识别治疗的成本过高，限制了医生和患者接受高质量和有效的解决方案。因此，治疗程序的高成本对整体治疗成本产生负面影响。因此，它将限制未来中低收入国家对治疗的需求。这表明，高成本的程序预计将成为欧洲炭疽病治疗市场增长的制约因素。

近期发展

2022 年 6 月，Emergent BioSolutions Inc. 宣布，美国食品药品监督管理局 (FDA) 接受了 AV7909 的生物制品许可申请 (BLA) 的审查，AV7909 是一种新的炭疽候选疫苗，用于评估 18 至 65 岁人群在疑似或确诊接触炭疽杆菌后，使用推荐的抗菌药物进行暴露后预防疾病。
2022 年 1 月，Alembic Pharmaceuticals Limited 宣布，该公司已获得美国食品药品监督管理局 (USFDA) 对其盐酸多西环素缓释片 USP、75 毫克、100 毫克、150 毫克和 200 毫克的简化新药申请 (ANDA) 的最终批准，该药仅用于治疗或预防已证实或强烈怀疑由易感细菌引起的感染。这扩大了公司的产品组合。

欧洲炭疽病治疗市场细分

欧洲炭疽病治疗市场根据类型、给药途径和最终用户分为三个显著的细分市场。细分市场之间的增长有助于您分析利基增长点和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

类型

皮肤炭疽
肺炭疽
肠炭疽

根据类型，欧洲炭疽病治疗市场分为皮肤炭疽病、肺炭疽病和肠炭疽病。

给药途径

皮肤炭疽
肺炭疽
肠炭疽

根据给药途径，欧洲炭疽病治疗市场分为口服、肠外和其他途径。

最终用户

政府组织
医院
学术及研究机构，
其他的

炭疽病治疗市场

根据最终用户，欧洲炭疽病治疗市场分为政府组织、医院、学术和研究机构等。

炭疽病治疗市场区域分析/见解

对欧洲炭疽病治疗市场进行了分析，并按类型、给药途径和最终用户提供了市场规模洞察和趋势。

炭疽病治疗报告涵盖的国家包括德国、法国、意大利、英国、西班牙、荷兰、俄罗斯、瑞士、土耳其、比利时和欧洲其他地区。

由于发展中地区的技术进步日益加快，预计德国将占据主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和炭疽病治疗市场份额分析

欧洲炭疽病治疗市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、欧洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对炭疽病治疗市场的关注有关。

市场的一些参与者包括 Alembic Pharmaceuticals、Sun Pharmaceutical Industries Ltd.、Zydus Group、Bayer AG、Pfizer Inc.、EMERGENT、Sanofi、Porton Biopharma、Lupin、Soligenix、Takeda Pharmaceutical Company Limited、Teva Pharmaceutical Industries Ltd.、ARISTO Pharmaceuticals Private Limited、INDOCO REMEDIES LTD.、DEINOVE 等。

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、欧洲与地区以及供应商份额分析。如有进一步询问，请要求分析师致电。

SKU-68919

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 POPULATION AT RISK (IN MILLIONS) BY REGION, LAND USE AND OCCUPATIONAL EXPOSURE, 2020-

TABLE 2 VACCINES IN DEVELOPMENT

TABLE 3 ANTIBIOTIC CONSUMPTION ESTIMATES BY GBD SUPER-REGION AND GBD REGION, FOR THE YEAR 2018-

TABLE 4 COUNTRY DATA OF ANTIBIOTICS CONSUMPTION-

TABLE 5 RECENT M&A IN ANTHRAX MARKET-

TABLE 6 ANTIBIOTICS MEDICINES

TABLE 7 FDA REQUIRES THE FOLLOWING SCENARIO BEFORE A DRUG IS APPROVED

TABLE 8 EUROPE ANTHRAX TREATMENT MARKET, TYPE, 2020-2029 (USD MILLION)

TABLE 9 EUROPE CUTANEOUS ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 EUROPE CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 11 EUROPE ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 EUROPE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 13 EUROPE BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 14 EUROPE BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 15 EUROPE ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 16 EUROPE VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 17 EUROPE PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 EUROPE PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 19 EUROPE ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 20 EUROPE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 21 EUROPE BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 22 EUROPE BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 23 EUROPE ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 24 EUROPE VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 25 EUROPE INTESTINAL ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 EUROPE INTESTINAL ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 27 EUROPE ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 28 EUROPE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 29 EUROPE BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 30 EUROPE BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 31 EUROPE ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 32 EUROPE VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 33 EUROPE ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 34 EUROPE PARENTERAL IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 EUROPE ORAL IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 EUROPE OTHERS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 EUROPE ANTHRAX TREATMENT MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 38 EUROPE GOVERNMENT ORGANIZATION IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 EUROPE HOSPITALS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 EUROPE ACADEMIC AND RESEARCH IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 EUROPE OTHERS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 EUROPE ANTHRAX TREATMENT MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 43 EUROPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 44 EUROPE CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 45 EUROPE ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 46 EUROPE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 47 EUROPE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 48 EUROPE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (ASP)

TABLE 49 EUROPE BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 50 EUROPE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 51 EUROPE BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 52 EUROPE BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 53 EUROPE ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 54 EUROPE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 55 EUROPE BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 56 EUROPE VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 57 EUROPE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 58 EUROPE BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (ASP)

TABLE 59 EUROPE PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 60 EUROPE ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 61 EUROPE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 62 EUROPE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 63 EUROPE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (ASP)

TABLE 64 EUROPE BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 65 EUROPE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 66 EUROPE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 67 EUROPE BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 68 EUROPE ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 69 EUROPE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 70 EUROPE BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 71 EUROPE VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 72 EUROPE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 73 EUROPE BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (ASP)

TABLE 74 EUROPE INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 75 EUROPE ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 76 EUROPE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 77 EUROPE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 78 EUROPE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (ASP)

TABLE 79 EUROPE BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 80 EUROPE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 81 EUROPE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 82 EUROPE BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 83 EUROPE ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 84 EUROPE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 85 EUROPE BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 86 EUROPE VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 87 EUROPE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 88 EUROPE BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (ASP)

TABLE 89 EUROPE ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 90 EUROPE ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 91 GERMANY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 92 GERMANY CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 93 GERMANY ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 94 GERMANY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 95 GERMANY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 96 GERMANY BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 97 GERMANY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 98 GERMANY BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 99 GERMANY ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 100 GERMANY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 101 GERMANY VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 102 GERMANY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 103 GERMANY PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 104 GERMANY ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 105 GERMANY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 106 GERMANY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 107 GERMANY BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 108 GERMANY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 109 GERMANY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 110 GERMANY ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 111 GERMANY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 112 GERMANY VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 113 GERMANY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 114 GERMANY INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 115 GERMANY ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 116 GERMANY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 117 GERMANY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 118 GERMANY BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 119 GERMANY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 120 GERMANY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 121 GERMANY ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 122 GERMANY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 123 GERMANY VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 124 GERMANY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 125 GERMANY ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 126 GERMANY ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 127 FRANCE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 128 FRANCE CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 129 FRANCE ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 130 FRANCE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 131 FRANCE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 132 FRANCE BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 133 FRANCE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 134 FRANCE BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 135 FRANCE ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 136 FRANCE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 137 FRANCE VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 138 FRANCE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 139 FRANCE PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 140 FRANCE ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 141 FRANCE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 142 FRANCE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 143 FRANCE BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 144 FRANCE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 145 FRANCE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 146 FRANCE ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 147 FRANCE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 148 FRANCE VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 149 FRANCE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 150 FRANCE INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 151 FRANCE ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 152 FRANCE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 153 FRANCE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 154 FRANCE BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 155 FRANCE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 156 FRANCE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 157 FRANCE ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 158 FRANCE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 159 FRANCE VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 160 FRANCE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 161 FRANCE ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 162 FRANCE ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 163 U.K. ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 164 U.K. CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 165 U.K. ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 166 U.K. BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 167 U.K. BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 168 U.K. BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 169 U.K. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 170 U.K. BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 171 U.K. ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 172 U.K. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 173 U.K. VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 174 U.K. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 175 U.K. PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 176 U.K. ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 177 U.K. BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 178 U.K. BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 179 U.K. BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 180 U.K. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 181 U.K. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 182 U.K. ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 183 U.K. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 184 U.K. VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 185 U.K. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 186 U.K. INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 187 U.K. ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 188 U.K. BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 189 U.K. BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 190 U.K. BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 191 U.K. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 192 U.K. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 193 U.K. ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 194 U.K. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 195 U.K. VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 196 U.K. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 197 U.K. ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 198 U.K. ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 199 ITALY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 200 ITALY CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 201 ITALY ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 202 ITALY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 203 ITALY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 204 ITALY BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 205 ITALY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 206 ITALY BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 207 ITALY ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 208 ITALY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 209 ITALY VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 210 ITALY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 211 ITALY PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 212 ITALY ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 213 ITALY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 214 ITALY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 215 ITALY BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 216 ITALY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 217 ITALY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 218 ITALY ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 219 ITALY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 220 ITALY VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 221 ITALY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 222 ITALY INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 223 ITALY ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 224 ITALY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 225 ITALY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 226 ITALY BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 227 ITALY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 228 ITALY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 229 ITALY ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 230 ITALY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 231 ITALY VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 232 ITALY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 233 ITALY ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 234 ITALY ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 235 RUSSIA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 236 RUSSIA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 237 RUSSIA ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 238 RUSSIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 239 RUSSIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 240 RUSSIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 241 RUSSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 242 RUSSIA BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 243 RUSSIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 244 RUSSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 245 RUSSIA VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 246 RUSSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 247 RUSSIA PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 248 RUSSIA ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 249 RUSSIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 250 RUSSIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 251 RUSSIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 252 RUSSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 253 RUSSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 254 RUSSIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 255 RUSSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 256 RUSSIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 257 RUSSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 258 RUSSIA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 259 RUSSIA ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 260 RUSSIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 261 RUSSIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 262 RUSSIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 263 RUSSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 264 RUSSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 265 RUSSIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 266 RUSSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 267 RUSSIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 268 RUSSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 269 RUSSIA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 270 RUSSIA ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 271 SPAIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 272 SPAIN CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 273 SPAIN ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 274 SPAIN BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 275 SPAIN BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 276 SPAIN BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 277 SPAIN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 278 SPAIN BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 279 SPAIN ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 280 SPAIN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 281 SPAIN VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 282 SPAIN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 283 SPAIN PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 284 SPAIN ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 285 SPAIN BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 286 SPAIN BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 287 SPAIN BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 288 SPAIN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 289 SPAIN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 290 SPAIN ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 291 SPAIN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 292 SPAIN VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 293 SPAIN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 294 SPAIN INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 295 SPAIN ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 296 SPAIN BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 297 SPAIN BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 298 SPAIN BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 299 SPAIN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 300 SPAIN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 301 SPAIN ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 302 SPAIN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 303 SPAIN VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 304 SPAIN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 305 SPAIN ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 306 SPAIN ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 307 TURKEY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 308 TURKEY CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 309 TURKEY ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 310 TURKEY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 311 TURKEY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 312 TURKEY BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 313 TURKEY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 314 TURKEY BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 315 TURKEY ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 316 TURKEY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 317 TURKEY VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 318 TURKEY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 319 TURKEY PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 320 TURKEY ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 321 TURKEY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 322 TURKEY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 323 TURKEY BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 324 TURKEY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 325 TURKEY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 326 TURKEY ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 327 TURKEY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 328 TURKEY VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 329 TURKEY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 330 TURKEY INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 331 TURKEY ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 332 TURKEY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 333 TURKEY BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 334 TURKEY BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 335 TURKEY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 336 TURKEY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 337 TURKEY ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 338 TURKEY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 339 TURKEY VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 340 TURKEY BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 341 TURKEY ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 342 TURKEY ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 343 NETHERLANDS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 344 NETHERLANDS CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 345 NETHERLANDS ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 346 NETHERLANDS BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 347 NETHERLANDS BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 348 NETHERLANDS BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 349 NETHERLANDS BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 350 NETHERLANDS BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 351 NETHERLANDS ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 352 NETHERLANDS BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 353 NETHERLANDS VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 354 NETHERLANDS BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 355 NETHERLANDS PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 356 NETHERLANDS ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 357 NETHERLANDS BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 358 NETHERLANDS BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 359 NETHERLANDS BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 360 NETHERLANDS BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 361 NETHERLANDS BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 362 NETHERLANDS ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 363 NETHERLANDS BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 364 NETHERLANDS VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 365 NETHERLANDS BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 366 NETHERLANDS INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 367 NETHERLANDS ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 368 NETHERLANDS BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 369 NETHERLANDS BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 370 NETHERLANDS BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 371 NETHERLANDS BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 372 NETHERLANDS BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 373 NETHERLANDS ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 374 NETHERLANDS BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 375 NETHERLANDS VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 376 NETHERLANDS BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 377 NETHERLANDS ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 378 NETHERLANDS ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 379 SWITZERLAND ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 380 SWITZERLAND CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 381 SWITZERLAND ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 382 SWITZERLAND BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 383 SWITZERLAND BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 384 SWITZERLAND BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 385 SWITZERLAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 386 SWITZERLAND BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 387 SWITZERLAND ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 388 SWITZERLAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 389 SWITZERLAND VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 390 SWITZERLAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 391 SWITZERLAND PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 392 SWITZERLAND ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 393 SWITZERLAND BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 394 SWITZERLAND BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 395 SWITZERLAND BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 396 SWITZERLAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 397 SWITZERLAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 398 SWITZERLAND ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 399 SWITZERLAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 400 SWITZERLAND VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 401 SWITZERLAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 402 SWITZERLAND INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 403 SWITZERLAND ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 404 SWITZERLAND BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 405 SWITZERLAND BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 406 SWITZERLAND BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 407 SWITZERLAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 408 SWITZERLAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 409 SWITZERLAND ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 410 SWITZERLAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 411 SWITZERLAND VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 412 SWITZERLAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 413 SWITZERLAND ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 414 SWITZERLAND ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 415 BELGIUM ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 416 BELGIUM CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 417 BELGIUM ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 418 BELGIUM BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 419 BELGIUM BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 420 BELGIUM BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 421 BELGIUM BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 422 BELGIUM BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 423 BELGIUM ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 424 BELGIUM BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 425 BELGIUM VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 426 BELGIUM BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 427 BELGIUM PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 428 BELGIUM ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 429 BELGIUM BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 430 BELGIUM BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 431 BELGIUM BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 432 BELGIUM BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 433 BELGIUM BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 434 BELGIUM ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 435 BELGIUM BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 436 BELGIUM VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 437 BELGIUM BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 438 BELGIUM INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 439 BELGIUM ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 440 BELGIUM BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 441 BELGIUM BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 442 BELGIUM BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 443 BELGIUM BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 444 BELGIUM BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 445 BELGIUM ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 446 BELGIUM BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 447 BELGIUM VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 448 BELGIUM BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 449 BELGIUM ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 450 BELGIUM ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 451 REST OF EUROPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 EUROPE ANTHRAX TREATMENT MARKET: SEGMENTATION

FIGURE 2 EUROPE ANTHRAX TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE ANTHRAX TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 EUROPE ANTHRAX TREATMENT MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 EUROPE ANTHRAX TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE ANTHRAX TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE ANTHRAX TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE ANTHRAX TREATMENT MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 EUROPE ANTHRAX TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE ANTHRAX TREATMENT MARKET: SEGMENTATION

FIGURE 11 MIDDLE EAST & AFRICA IS ANTICIPATED TO DOMINATE THE ANTHRAX TREATMENT MARKET AND GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 INCREASING INCIDENCE AND PREVALENCE OF ANTHRAX INFECTIONS ARE EXPECTED TO DRIVE THE EUROPE ANTHRAX TREATMENT MARKET IN THE FORECAST PERIOD

FIGURE 13 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ANTHRAX TREATMENT MARKET IN 2022 & 2029

FIGURE 14 EUROPE DISTRIBUTION OF OUTBREAKS BY COUNTRY AND GEOGRAPHIC LOCATIONS OF ANTHRAX EVENTS-

FIGURE 15 PATHOPHYSIOLOGY OF ANTHRAX-

FIGURE 16 FLOW CHART FOR SUSPECTED ANTHRAX EXPOSURE-

FIGURE 17 GC BIOPHARMA ANTHRAX CANDIDATE GC1109 IS IN PHASE 2 (NCT01624532).

FIGURE 18 BA-ISTAB IS A FUSION OF A B. ANTHRACIS SPECIFIC CWT WITH A POTENT MONOCLONAL ANTIBODY THAT NEUTRALIZE ANTHRAX TOXIN (PA).

FIGURE 19 TWO ROUTES BY WHICH VACCINATION CAN REDUCE INCIDENCE OF AMR-

FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE ANTHRAX TREATMENT MARKET

FIGURE 21 EUROPE ANTHRAX TREATMENT MARKET : TYPE, 2021

FIGURE 22 EUROPE ANTHRAX TREATMENT MARKET : TYPE, 2022-2029 (USD MILLION)

FIGURE 23 EUROPE ANTHRAX TREATMENT MARKET : TYPE, CAGR (2022-2029)

FIGURE 24 EUROPE ANTHRAX TREATMENT MARKET : TYPE, LIFELINE CURVE

FIGURE 25 EUROPE ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, 2021

FIGURE 26 EUROPE ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, 2022-2029 (USD MILLION)

FIGURE 27 EUROPE ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)

FIGURE 28 EUROPE ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 29 EUROPE ANTHRAX TREATMENT MARKET : BY END USER, 2021

FIGURE 30 EUROPE ANTHRAX TREATMENT MARKET : BY END USER, 2022-2029 (USD MILLION)

FIGURE 31 EUROPE ANTHRAX TREATMENT MARKET : BY END USER, CAGR (2022-2029)

FIGURE 32 EUROPE ANTHRAX TREATMENT MARKET : BY END USER, LIFELINE CURVE

FIGURE 33 EUROPE ANTHRAX TREATMENT MARKET: SNAPSHOT (2021)

FIGURE 34 EUROPE ANTHRAX TREATMENT MARKET: BY COUNTRY (2021)

FIGURE 35 EUROPE ANTHRAX TREATMENT MARKET: BY COUNTRY (2022 & 2029)

FIGURE 36 EUROPE ANTHRAX TREATMENT MARKET: BY COUNTRY (2021 & 2029)

FIGURE 37 EUROPE ANTHRAX TREATMENT MARKET: BY TYPE (2022-2029)

FIGURE 38 EUROPE ANTHRAX TREATMENT MARKET: COMPANY SHARE 2021(%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.